Moderna has rejected claims that U.S. government scientists co-invented a critical part of its coronavirus vaccine, escalating what's become a messy dispute between the company and its longtime research partners at the National Institutes of Health.
The biotech on Wednesday said it disagrees that NIH scientists co-created the genetic sequence used in its COVID-19 shot, a key discovery that underlies the intellectual property covering the vaccine. That sequence was chosen "by Moderna scientists using Moderna technology" and NIH scientists weren't involved until after a patent request had been filed, the
The statement comes as the year-long disagreement between the NIH and Moderna could reportedly soon be headed to court. Moderna's shot, one of the world's most lucrative COVID-19 vaccines, has mainly been bought by wealthier nations
